gbr 12935 has been researched along with Dyskinesia, Medication-Induced in 1 studies
1-[2-(benzhydryloxy)ethyl]-4-(3-phenylpropyl)piperazine : An N-alkylpiperazine that consists of piperazine bearing 2-(benzhydryloxy)ethyl and 3-phenylpropyl groups at positions 1 and 4 respectively. Potent and selective inhibitor of dopamine uptake (KD = 5.5 nM in rat striatal membranes).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Knable, MB | 1 |
| Hyde, TM | 1 |
| Egan, MF | 1 |
| Tosayali, M | 1 |
| Wyatt, RJ | 1 |
| Kleinman, JE | 1 |
1 other study available for gbr 12935 and Dyskinesia, Medication-Induced
| Article | Year |
|---|---|
Quantitative autoradiography of striatal dopamine D1, D2 and re-uptake sites in rats with vacuous chewing movements.
Topics: Animals; Autoradiography; Benzazepines; Biological Transport; Corpus Striatum; Dopamine; Dopamine D2 | 1994 |